| CAPITAL GROUP NEW PERSPECTIVE FUND (LUX) PH CHF | RVI GLOBAL | 27,022982 | 15/12/2025 | 12,49% | 57,69% | ***** |
| POLAR CAPITAL BIOTECHNOLOGY S GBP DIS | BIOTECNOLOGÍA | 59,380339 | 15/12/2025 | 25,73% | 57,68% | **** |
| INVESCO S&P 500 UCITS ETF DIST | RVI USA | 53,733089 | 15/12/2025 | 2,30% | 57,66% | *** |
| ROBECO QI EMERGING MARKETS ACTIVE EQUITIES F EUR | RVI EMERGENTES | 268,330000 | 15/12/2025 | 11,99% | 57,65% | ***** |
| ISHARES DEVELOPED WORLD INDEX FUND (IE) INSTITUTIONAL USD ACC | RVI GLOBAL | 37,022037 | 15/12/2025 | 6,66% | 57,64% | **** |
| PRIVILEDGE - JPMORGAN US EQUITIES BETA ENHANCED (USD) I CAP | RVI USA | 42,508397 | 12/12/2025 | 2,07% | 57,64% | ** |
| CAIXABANK MASTER RENTA VARIABLE USA ADVISED BY, FI | RVI USA | 13,678400 | 14/12/2025 | 1,71% | 57,63% | *** |
| GOLDMAN SACHS MULTI-MANAGER GLOBAL EQUITY PORTFOLIO OTHER CURRENCY CAP EUR | RVI GLOBAL | 19,720000 | 15/12/2025 | 7,06% | 57,63% | **** |
| SCHRODER ISF GLOBAL EQUITY ALPHA C ACC EUR | RVI GLOBAL VALOR | 455,457600 | 15/12/2025 | 6,96% | 57,62% | **** |
| BLACKROCK EMERGING MARKETS EQUITY STRATEGIES E2 EUR | RVI EMERGENTES | 261,010000 | 15/12/2025 | 23,13% | 57,61% | ***** |
